Prospective evaluation of minimal residual disease in multiple myeloma following autologous stem cell transplantation(ASCT) and consolidation therapy.

被引：0
|
作者：
Patekar, Mukesh
Kumar, Lalit
Sharma, Atul
Gupta, Ritu
Vishnubhatla, Sreenivas
Naik, Ramavath Devendra
Pai, Rohit Ramesh
Tiwari, Akash
Dahiya, Meetu
机构：
[1] AIIMS, New Delhi, India
[2] All India Inst Med Sci, Dept Biostat, New Delhi, India
[3] All India Inst Med Sci, Dr BRA Inst Rotary Canc Hosp, New Delhi, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20033
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prognostic impact of natural killer cell recovery on minimal residual disease after autologous stem cell transplantation in multiple myeloma
    Keruakous, Amany R.
    Asch, Adam
    Aljumaily, Raid
    Zhao, Daniel
    Yuen, Carrie
    TRANSPLANT IMMUNOLOGY, 2022, 71
  • [22] Minimal residual disease (MRD) status pre- and post-high-dose therapy/autologous stem (HDC/ASCT) cell transplantation for multiple myeloma (MM) in the era of novel agents
    Kassim, Adetola
    McDuffie, Jeremy Scott
    Mosse, Claudio A.
    Savani, Bipin N.
    Greer, John P.
    Oluwole, Olalekan O.
    Goodman, Stacey
    Engelhardt, Brian G.
    Chinratanalab, Wichai
    Kim, Annette S.
    Jagasia, Madan H.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
    Mohan, Meera
    Gundarlapalli, Sravani
    Szabo, Aniko
    Yarlagadda, Naveen
    Kakadia, Sunilkumar
    Konda, Manojna
    Jillella, Anusha
    Fnu, Amisha
    Ogunsesan, Yetunde
    Yarlagadda, Lakshmi
    Thalambedu, Nishant
    Munawar, Hussain
    Graziutti, Monica
    Al Hadidi, Samer
    Alapat, Daisy
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    van Rhee, Frits
    Schinke, Carolina
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : E195 - E198
  • [24] The clinical significance of the monitoring minimal residual disease for maintanence therapy after autologous stem cells transplantation in patients with multiple myeloma
    Shamansky, S.
    Fedotova, I.
    Novoseltceva, L.
    Melkova, C.
    Pisarevskaya, O.
    Rukavitcin, O.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5597 - 5598
  • [25] The evolving role of maintenance therapy following autologous stem cell transplantation in multiple myeloma
    Merz, Almuth Maria Anni
    Merz, Maximilian
    Hillengass, Jens
    Holstein, Sarah A.
    McCarthy, Philip
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (10) : 889 - 898
  • [26] Leopard: A Phase II Study of Maintenance Lenalidomide and Prednisolone Post Autologous Stem Cell Transplantation (ASCT) for Myeloma, Incorporating Minimal Residual Disease Assessments
    Kalff, Anna
    Kennedy, Nola
    Walker, Patricia A.
    Khong, Tiffany T.
    Schwarer, Anthony
    Roberts, Andrew W.
    Campbell, Philip
    Filshie, Robin
    Smiley, Angela
    Gorniak, Malgorzata
    Black, Marion
    Jenkins, Nicole
    Raines, Geoffrey
    Spencer, Andrew
    BLOOD, 2014, 124 (21)
  • [27] Immune Profiling of Newly Diagnosed Multiple Myeloma (NDMM) Treated with Quadruplet Induction and Autologous Stem Cell Transplantation (ASCT) and Comparison with Achievement of Minimal Residual Disease (MRD) Negativity
    Bal, Susan
    Zumaquero, Esther
    Ravi, Gayathri
    Godby, Kelly
    Giri, Smith
    Denslow, Ashley
    Perez, Joaquin Bauta
    Zhou, Fen
    Chen, Suki
    Padilla, Megan
    Siddiqui, Amna
    Ubersax, Clare
    Hornsby, Erin
    Costa, Luciano
    Lund, Frances E.
    BLOOD, 2023, 142
  • [28] Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma
    Gojo, I
    Meisenberg, B
    Guo, C
    Fassas, A
    Murthy, A
    Fenton, R
    Takebe, N
    Heyman, M
    Philips, G
    Cottler-Fox, M
    Sarkodee-Adoo, C
    Ruehle, K
    French, T
    Tan, M
    Tricot, G
    Rapoport, AP
    BONE MARROW TRANSPLANTATION, 2006, 37 (01) : 65 - 72
  • [29] Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma
    I Gojo
    B Meisenberg
    C Guo
    A Fassas
    A Murthy
    R Fenton
    N Takebe
    M Heyman
    G L Philips
    M Cottler-Fox
    C Sarkodee-Adoo
    K Ruehle
    T French
    M Tan
    G Tricot
    A P Rapoport
    Bone Marrow Transplantation, 2006, 37 : 65 - 72
  • [30] Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: A retrospective study
    Liu, Hong
    Yuan, Constance
    Heinerich, Jeremy
    Braylan, Raul
    Chang, Myron
    Wingard, John
    Moreb, Jan
    LEUKEMIA & LYMPHOMA, 2008, 49 (02) : 306 - 314
12345